MET and alveolar rhabdomyosarcoma: RH4 and RH30, two human ARMS cell lines harbouring PAX3-FOXO1 translocation, and with raised ALK and MET expression [11, 14], were treated with crizotinib to evaluate the effects on cell proliferation, apoptosis, autophagy, colony formation ability and cell cycle as well as on several specific molecular pathways.